{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:17:27Z","timestamp":1779344247049,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1998,3,1]],"date-time":"1998-03-01T00:00:00Z","timestamp":888710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1998,3]]},"DOI":"10.1038\/nm0398-336","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T01:57:35Z","timestamp":1092880655000},"page":"336-340","source":"Crossref","is-referenced-by-count":479,"title":["Vascular endothelial growth factor is essential for corpus luteum angiogenesis"],"prefix":"10.1038","volume":"4","author":[{"given":"Napoleone","family":"Ferrara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terri","family":"Davis-Smyth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thuy-Nhung","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Peers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth J.","family":"Hillan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph H.","family":"Schwall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnm0398336_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/aja.1000730206","volume":"73","author":"DEL Bassett","year":"1943","unstructured":"Bassett, D.E.L. The changes in the vascular pattern of the ovary of the albino rat during the estrous cycle. Am. J. Anat. 73, 251\u2013278 (1943).","journal-title":"Am. J. Anat."},{"key":"BFnm0398336_CR2","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1073\/pnas.75.2.847","volume":"75","author":"D Gospodarowicz","year":"1978","unstructured":"Gospodarowicz, D. & Takral, T.K. Production of a corpus luteum angiogenic factor responsible for proliferation of capillaries and neovascularization of the corpus luteum. Proc. Natl. Acad. Sci. USA 75, 847\u2013851 (1978).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"BFnm0398336_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","volume":"18","author":"Napoleone Ferrara","year":"1997","unstructured":"Ferrara, N. & Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr. Rev. 18, 4\u201325(1997).","journal-title":"Endocrine Reviews"},{"key":"BFnm0398336_CR4","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1210\/endo-127-2-965","volume":"127","author":"HS Phillips","year":"1990","unstructured":"Phillips, H.S., Hains, J., Leung, D.W. & Ferrara, N. Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology 127, 965\u2013967 (1990).","journal-title":"Endocrinology"},{"key":"BFnm0398336_CR5","unstructured":"Kamat, B.R., Brown, L.F., Manseau, E.J., Senger, D.R. & Dvorak, H.F. Expression of vascular permeability factor\/vascular endothelial growth factor by human granu-losa and theca lutein cells: Role in corpus luteum development. Am. J. Pathol. 146, 157\u2013165(1995)."},{"key":"BFnm0398336_CR6","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1172\/JCI116450","volume":"91","author":"D Shweiki","year":"1993","unstructured":"Shweiki, D., Itin, A., Neufeld C., Gitay-Goren, H. & Keshet, E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally-mediated angiogenesis. J. Clin. Invest. 91, 2235\u20132243 (1993).","journal-title":"J. Clin. Invest."},{"key":"BFnm0398336_CR7","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1210\/endo-117-6-2383","volume":"117","author":"D Gospodarowicz","year":"1985","unstructured":"Gospodarowicz, D., Cheng, J., Lui, G.M., Baird, A. & Bohlen, P. Corpus luteum angiogenesis factor is related to fibroblast growth factor. Endocrinology 117, 2283\u20132290 (1985).","journal-title":"Endocrinology"},{"key":"BFnm0398336_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.277.5322.55","volume":"277","author":"PC Maisonpierre","year":"1997","unstructured":"Maisonpierre, P.C. et al. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. Science 277, 55\u201360 (1997).","journal-title":"Science"},{"key":"BFnm0398336_CR9","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1126\/science.1312256","volume":"255","author":"C de Vries","year":"1992","unstructured":"de Vries, C. et al. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989\u2013991 (1992).","journal-title":"Science"},{"key":"BFnm0398336_CR10","doi-asserted-by":"publisher","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","volume":"92","author":"LP Aiello","year":"1995","unstructured":"Aiello, L.P. et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. USA 92, 10457\u201310461 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm0398336_CR11","first-page":"324","volume":"226","author":"RL Kendall","year":"1996","unstructured":"Kendall, R.L., Wang, G. & Thomas, K.A. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem. Biophys. Res. Commun. 226, 324\u2013328 (1996).","journal-title":"Biochem. Biophys."},{"key":"BFnm0398336_CR12","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1002\/j.1460-2075.1996.tb00872.x","volume":"15","author":"T Davis-Smyth","year":"1996","unstructured":"Davis-Smyth, T., Chen, H., Park, J., Presta, L.G. & Ferrara, N. The second im-munoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J. 15, 4919\u20134927 (1996).","journal-title":"EMBO J."},{"key":"BFnm0398336_CR13","first-page":"46","volume-title":"Maximizing yield and developmental uniformity of eggs, in Methods in Mammalian Embryology","author":"AH Gates","year":"1971","unstructured":"Gates, A.H. Maximizing yield and developmental uniformity of eggs, in Methods in Mammalian Embryology. (ed. Daniels, J.) 46\u201376 (Freeman, San Francisco, 1971)."},{"key":"BFnm0398336_CR14","doi-asserted-by":"crossref","unstructured":"Rothchild, I. The regulation of the mammalian corpus luteum. Rec. Prog. Horm. Res. 37, 183\u2013298(1981).","DOI":"10.1016\/B978-0-12-571137-1.50009-8"},{"key":"BFnm0398336_CR15","doi-asserted-by":"crossref","unstructured":"Park, J.E., Chen, H.H., Winer, J., Houck, K.A. & Ferrara, N. Placenta growth factor: Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1\/KDR. J. Biol. Chem. 269, 25646\u201325654(1994).","DOI":"10.1016\/S0021-9258(18)47298-5"},{"key":"BFnm0398336_CR16","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1074\/jbc.271.6.3154","volume":"271","author":"Y Cao","year":"1996","unstructured":"Cao, Y. et al. Heterodimers of placenta growth factor\/vascular endothelial growth factor: Endothelial activity, tumor cell expression, and high affinity binding to Flk-1\/KDR J. Biol. Chem. 271, 3154\u20133162 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnm0398336_CR17","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1126\/science.276.5319.1706","volume":"276","author":"LE Smith","year":"1997","unstructured":"Smith, L.E. et al. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276, 1706\u20131709 (1997).","journal-title":"Science"},{"key":"BFnm0398336_CR18","first-page":"325","volume":"22","author":"JW Goldziher","year":"1962","unstructured":"Goldziher, J.W. & Green, J.A. The polycystic ovary. I. Clinical and histologic features. J. Clin. Endocrinol. Metab. 22, 325\u2013332 (1962).","journal-title":"J. Clin."},{"key":"BFnm0398336_CR19","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/0002-9378(72)90180-9","volume":"112","author":"T Engel","year":"1972","unstructured":"Engel, T., Jewelewicz, R., Dyrenfurth, I., Speroff, L. & Vande Wiele, R.L. Ovarian hy-perstimulation syndrome: Report of one case with notes on pathogenesis and treatment. Am. J. Obstet. Cynecol. 112, 1052\u20131057 (1972).","journal-title":"Am. J. Obstet. Cynecol."},{"key":"BFnm0398336_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0140-6736(94)93001-5","volume":"344","author":"N McClure","year":"1994","unstructured":"McClure, N. et al. Vascular endothelial growth factor as a capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 344, 235\u2013269 (1994).","journal-title":"Lancet"},{"key":"BFnm0398336_CR21","first-page":"758","volume":"36","author":"YS Murthy","year":"1970","unstructured":"Murthy, Y.S., Arronet, G.H. & Pareck, M.C. Luteal phase inadequacy. Obstet. Gynecol. 36, 758\u2013772 (1970).","journal-title":"Obstet. Gynecol."},{"key":"BFnm0398336_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/337525a0","volume":"337","author":"DJ Capon","year":"1989","unstructured":"Capon, D.J. et al. Designing CD4 immunoadhesins for AIDS therapy. Nature 337, 525\u2013531 (1989).","journal-title":"Nature"},{"key":"BFnm0398336_CR23","first-page":"2293","volume":"8","author":"H Finnerty","year":"1993","unstructured":"Finnerty, H. et al. Molecular cloning of murine FLT and FLT4. Oncogene 8, 2293\u20132298 (1993).","journal-title":"Oncogene"},{"key":"BFnm0398336_CR24","unstructured":"Lucas, B.K. et al. High-level production of recombinant proteins using dicistronic DHFR into expression vector. Nucleic Acid Res. 24, 1774\u20131779 (1996)."},{"key":"BFnm0398336_CR25","first-page":"1","volume-title":"High efficiency gene transfer into mammalian cells, in DNA Cloning 4: A Practical Approach, Mammalian systems","author":"V Chisholm","year":"1995","unstructured":"Chisholm, V. High efficiency gene transfer into mammalian cells, in DNA Cloning 4: A Practical Approach, Mammalian systems,(eds. Glover, D.M. & Hames, B.D.) 1\u201339 (Oxford University Press, New York 1995)."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0398-336","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0398-336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0398-336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:12:18Z","timestamp":1684447938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0398-336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,3]]}},"alternative-id":["BFnm0398336"],"URL":"https:\/\/doi.org\/10.1038\/nm0398-336","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,3]]}}}